Skip to main content

Table 1 Characteristics

From: Patients with acute exacerbation of chronic obstructive pulmonary disease feel safe when treated at home: a qualitative study

Hospital at home treatment programme

Hospital care

On admission

Sex

Female

Female

Female

Male

Male

Male

Female

Female

Male

Age (yrs)

51

71

71

70

71

79

54

77

77

Marital status

Married

Widow

Widow

Married

Married

Married

Divorced

Widow

Married

Comorbidities

Anxiety Depression

Heart Disease Hypertension

Heart Disease Hypertension

Hypertension

Diabetes mellitus Hypertension

Diabetes mellitus Hypertension

Anxiety

Diabetes mellitus Inflammatory bowel disease

Heart disease

GOLD stage

II

I

III

III

III

II

III

III

III

Blood pressure (mmHg)

150/80

180/80

140/75

155/90

150/90

140/70

140/75

150/80

97/53

Pulse rate min-1

108

56

87

75

88

61

105

110

60

PaO2 (kPa)

8.27

8.45

10.9

7.57

11.4

8.93

9.18

8.74

8.13

Respiratory rate min-1

24

22

20

35

24

18

17

20

25

Number of drugs

5

8

8

5

8

10

5

8

8

At 6 weeks control

FEV1 (l/s) (% of predicted)

1.68 (59%)

1.89 (97%)

0.5 (31%)

1.4 (37%)

1.3 (40%)

2.1 (75%)

0.9 (39%)

0.8 (41%)

1.3 (42%)

MRC dyspnoea scale

5

3

3

2

2

2

3

4

2

BMI (kg/m2)

41

33

24

38

33

30

30

26

24

6-minute walk test (m)

*

508

272

500

125

510

280

350

500

  1. IBD: Inflammatory bowel disease; GOLD: Global Initiative for Chronic Obstructive Lunge Disease; PaO2: arterial oxygen tension; FEV1: forced expiratory volume in one second; MRC: Medical Research Council dyspnoea scale, range (1–5); BMI: Body mass index; *not carried out due to a knee injury.